Concord Biotech Board Meeting on May 29, 2026

Board Meeting Details

The Board of Directors meeting will be held on Friday, May 29, 2026. The agenda includes:

• Consideration and approval of audited Standalone and Consolidated Financial Results for the fourth quarter and financial year ended March 31, 2026
• Review of audit report to be issued by the Statutory Auditors
• Recommendation of final dividend on equity shares, subject to approval of shareholders at the ensuing Annual General Meeting
• Consideration of other business matters

Trading Window Closure

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct, the trading window for dealing in the Company's securities remains closed. This closure is in continuation of the earlier intimation dated March 27, 2026. The trading window will remain closed up to 48 hours after the declaration of the Financial Results for the fourth quarter and financial year ended March 31, 2026.